Johns Hopkins Medicine: DNA Shed by Colon Cancers May Help Oncologists Personalize Postsurgical Treatment
October 21, 2025
October 21, 2025
BALTIMORE, Maryland, Oct. 21 (TNSjou) -- Johns Hopkins Medicine issued the following news release:
* * *
DNA Shed by Colon Cancers May Help Oncologists Personalize Postsurgical Treatment
Circulating tumor DNA (ctDNA) -- genetic material shed from tumors into the bloodstream -- may help risk-stratify patients with Stage 3 colon cancer by tailoring chemotherapy options after surgery based on risk of cancer recurrence, according to new research co-led by inves . . .
* * *
DNA Shed by Colon Cancers May Help Oncologists Personalize Postsurgical Treatment
Circulating tumor DNA (ctDNA) -- genetic material shed from tumors into the bloodstream -- may help risk-stratify patients with Stage 3 colon cancer by tailoring chemotherapy options after surgery based on risk of cancer recurrence, according to new research co-led by inves . . .